Co-Enrolment
Find below a list of trials iRehab can co-enrol with.
These trials have been considered by their respective trial management groups and Chief Investigators. This process has taken into consideration any potential issues regarding study design and statistical considerations; biological and scientific considerations; implications of co-enrolment on participants and their relatives; legal and ethical issues; logical and organisational considerations.
Approved co-enrolling trials:
- ADAPT-SepsisLink opens in a new window
- AIRWAYS-3Link opens in a new window
- Awake Prone (CoReCCT)
- CandiResLink opens in a new window
- Colo-Pro 2
- ED-POC
- FLAIR
- FRECycl-D
- GRACE
- Hypersensitivity
- InCyst Study
- INFINIT
- Innate
- Nava (CoReCCT)
- NOTE-AF
- PLACID
- PREFIBRILLATE
- PRONTO
- Protect (CoReCCT)
- PROVE
- Release (CoReCCT)
- RMCIP
- Salford Kidney Study
- SEACTV
- SEISMIC-R
- SHORTER
- SINFONIA
- SNAP
- SOSLink opens in a new window
- TDM-TIME
- including
- Vital
New trials will be added in due course following discussions with the respective trial management groups and Chief Investigators. If you have any further queries or wish to discuss additional trials, please contact the iRehab trial team.
Enquiries:
Please direct all enquiries to the iRehab team;
Kerry Raynes: Trial Manager
Sarah Lowe, Trial Manager
Katherine Jones, Research Fellow
Email: iRehab@warwick.ac.uk
Tel: 02476151367